
Enhanced cytotoxicity with a novel system combining the paclitaxel-2′-ethylcarbonate prodrug and an HSV amplicon with an attenuated replication-competent virus, HF10 as a helper virus
Keywords: Oncolytic virus HSV-1 HF10; Gene directed enzyme prodrug therapy (GDEPT); HSV amplicon; Carboxylesterase (CES); Paclitaxel-2′-ethylcarbonate prodrug (TAX-2′-Et)